Antje Mohs
Aachen, NW 52074, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Journal: Nature communications
Published: July 25, 2022
ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression.
Journal: Cell death & disease
Published: May 27, 2022
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression.
Journal: Redox biology
Published: October 07, 2021
Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
Journal: Nature metabolism
Published: May 10, 2021
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment.
Journal: Nature communications
Published: December 02, 2020
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury.
Journal: Cellular and molecular gastroenterology and hepatology
Published: June 02, 2020
Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Journal: Journal of hepatology
Published: April 17, 2020
Disturbed gut microbiota and bile homeostasis in Giardia-infected mice contributes to metabolic dysregulation and growth impairment.
Journal: Science translational medicine
Published: July 11, 2019
Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
Journal: International journal of molecular sciences
Published: November 14, 2018
MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
Journal: Carcinogenesis
Published: July 26, 2018
Last Updated: 09/26/2026